Covered recipient · General Payments record
THOMAS A THACKER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,177.31
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $155.49 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $33.90 | 2 |
| Amgen Inc. | $30.47 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.71 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.43 | 1 |
| Exact Sciences Corporation | $17.51 | 1 |
| Paratek Pharmaceuticals, Inc. | $16.75 | 1 |
| Lilly USA, LLC | $14.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.73 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117699480 | CMS |
| Amgen Inc. | $14.74 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117699482 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.71 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118236490 | CMS |
| Exact Sciences Corporation | $17.51 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114930026 | CMS |
| Lilly USA, LLC | $14.72 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135491858 | CMS |
| Novo Nordisk Inc | $16.67 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096717998 | CMS |
| Novo Nordisk Inc | $17.23 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097594225 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.43 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118992966 | CMS |
| Paratek Pharmaceuticals, Inc. | $16.75 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113921446 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.